Barinthus Biotherapeutics plc ( VACC) - Stock Earnings

VACC Quarterly earnings

DateEarningsRevenue
2022Q2 15.7 million USD 17.1 million USD
2022Q3 8.2 million USD 6.2 million USD
2022Q4 -21.2 million USD 6.5 million USD

VACC Yearly earnings

DateEarningsRevenue
2020 -17.7 million USD 4.8 million USD
2021 -50.9 million USD 268000 USD
2022 5.3 million USD 44.7 million USD

VACC

Price: $5

52 week price:
1.64
5.10

Earnings Per Share: -1.87 USD

P/E Ratio: 15.64

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 171964

Market Capitalization: 192.7 million

Links: